Comparative study of the effects of adamantane derivatives on the behavior of CD-1 mice with different phenotype of attention stability
Animal research · 2022
- What was studied
- CD-1 mice separated by baseline attention phenotype; three administrations
- Main finding
- Cyclantane, Ladasten and memantine partially restored attention in the low-attention subgroup, but worsened attention in the initially high-attention subgroup by 40–47% relative to controls. Exploratory and locomotor measures did not change in parallel.
Study data at a glance
- Participants or experimental model
- CD-1 mice separated by baseline attention phenotype; three administrations
- Reported results
- Cyclantane, Ladasten and memantine partially restored attention in the low-attention subgroup, but worsened attention in the initially high-attention subgroup by 40–47% relative to controls. Exploratory and locomotor measures did not change in parallel.
Study limitations and source details
Study limitations
- Phenotype-dependent mouse behavior is not evidence for human ADHD treatment or general cognitive enhancement.
- Dose, route and repeated-testing effects limit extrapolation; the names Cyclantane and Cyclontane refer here to ADK-638.
Source details
Journal article; full-text reproduction
Selected source passages checked; complete methods and risk of bias not appraised.
Abstract, identity passage and selected methods reviewed
Sources checked
Citation
N. A. Sukhorukova, R. M. Salimov, G. I. Kovalev. Comparative study of the effects of adamantane derivatives on the behavior of CD-1 mice with different phenotype of attention stability Pharmacokinetics and Pharmacodynamics. 2022;(1):3–8
Study source ↗ · DOI 10.37489/2587-7836-2022-1-3-8 · Bibliography entry · Link to this summary
Related compounds
Cyclontane
A synthetic adamantane derivative, also called ADK-638, studied on its own and in a formulation with sodium oxybate.
Bromantane
A synthetic adamantane drug, also called Ladasten, studied in Russian fatigue and stress research.